Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research
Empagliflozin Outcome on Obstructive Sleep Apnea, Cardiovascular, and Renal Events
The Impact of Polypharmacy in Elderly Patients with Type 2 Diabetes
Sotagliflozin: Implications in Patients Living With Chronic Kidney Disease
MOST POPULAR ARTICLES OF THE MONTH
#1 Pumping Up with Protein: Does This Work for Exercise and Health?
#2 The Promising Future of Oral Insulin
#3 Low Carbohydrate Diets the Future for Weight Loss in Obesity
Letter from the Editor
Years ago I delivered a CE for pharmacists on the relation of diabetes and obstructive sleep apnea. I went back and looked at the data, and there was a strong correlation between OSA, hypertension and diabetes.
Typically getting a patient on a CPAP device is the only choice available, but now new research on a well known diabetes drug shows reduction in sleep apnea in these patients, while also reducing A1c and cardiovascular risk.
Check out our feature article from Tarshay Boyd, PharmD. Candidate, LECOM School of Pharmacy, to learn what this medication is.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
TOP STORIES — Diabetes News and Research
The unique benefits of using empagliflozin need to be considered when determining treatments for type 2 patients.
Can the use of polypharmacy put patients at increased risk for hospitalization, falls, and all-cause mortality?
A new phase 3 study on novel SGLT inhibitor shows favorable results in those living with severe renal impairment.